Pfizer Pilot Procedure

Superior Essays
With respect to the above matter, we take note of the feedback from Pfizer on the negative experience with the pilot procedure on collaborative registration of products approved by stringent regulatory authorities (SRA). The objective of the pilot procedure, which is a voluntary process for all parties, was to assess the feasibility of collaboration in exchange of information (assessment and inspection reports) between a stringent regulatory authority “SRA” and respective national medicines regulatory authorities (NMRAs) in accelerating national registrations. Therefore, the feedback received from Pfizer is essential in assessing the utility of the procedure and address observed challenges.

Medroxyprogesterone acetate (MPA) was the third active drug substance to be included in the SRA pilot procedure. To date, we have 5 drug substances (9 products in total) through this procedure. For clarity, below are the basic principles of the procedure, since it appears there is some misunderstanding.
1. A valid submission should be submitted to the NMRAs using the usual channels of communication and complying with local requirements. Since the procedure is to assist in the technical review, it was agreed
…show more content…
Similarly, Pfizer was to submit responses to each NMRA using normal procedures. Further action on any pending issues after the second review were to be addressed as usual by the individual NMRAs. Essentially, WHO’s role in the process was only limited to coordinating with the MHRA, Pfizer and NMRAs to initiate the procedure, and facilitate the two rounds of reviews. Thereafter, each NMRA had to finalise any outstanding issues and make a regulatory decision and inform Pfizer as per normal registration procedures. Afterwards, WHO’s role was to monitor the outcomes based on feedback from Pfizer (or NMRAs) and intervene when

Related Documents

  • Improved Essays

    Cleanflo Case Study

    • 779 Words
    • 4 Pages

    The Horizon chemical company discovered that its product (Cleanflo), sold for the purpose of cleaning dairy apparatus, also was extremely effective in dissolving the calcium deposits, which clogged catheters that had been removed from the body. Consequently, the Horizon prepared and distributed brochures to the physicians and hospitals to promote the product, for these purposes. The FDA argued that Cleanflo was a drug and that the bottle and brochures were misbranded because they did not contain the label and labeling information required by the law. According to the section 301 (d) of the Food, Drug, and Cosmetic Act, 21 U.S.C. § 331 (d), prohibits the introduction in to interstate commerce of any section 505 of the FDCA, 21 U.S.C. § 355. Section 505 (a), in turn, prohibits any person from introducing or delivering for introduction into interstate commerce any “new drug” unless the FDA has approved the…

    • 779 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    These two methods in the articles described a way to change the regulation of how pharmaceuticals adjust their…

    • 1525 Words
    • 7 Pages
    Improved Essays
  • Great Essays

    Fda Case Study

    • 1215 Words
    • 5 Pages

    1.1 Background The mission of the FDA Office of Financial Management (OFM), Division of Financial System Support (DFSS) is to coordinate the management of FDA’s financial system of record Unified Financial Management System (UFMS) with Health and Human Services (HHS) and the other HHS Operating Divisions (OpDivs) who currently use UFMS. UFMS is the HHS department wide financial system of record. The HHS Financial Enterprise System Management (FESM) organization is responsible for managing the global UFMS. DFSS ensures that the functionalities within UFMS meets FDA’s business needs and processes, any changes proposed by other OpDivs or HHS are communicated to our end users and that it does not break our internal financial business processes.…

    • 1215 Words
    • 5 Pages
    Great Essays
  • Improved Essays

    It would be expected for the Food and Drug Administration to approve these supplements before marketing them to…

    • 426 Words
    • 2 Pages
    Improved Essays
  • Decent Essays

    The topic I choose for this assignment is “Study Drugs”. The two sources I used for my assignment are Motlow’s library and Gale General OneFile Database. Both of these sources I used were chosen from peer review only. Using the database inside the library and double check to make sure they were peer reviewed in order to be certain the credibility of the sources are legitimate.…

    • 202 Words
    • 1 Pages
    Decent Essays
  • Improved Essays

    The IG MPI Investigations Division conducts investigations of Medicaid providers regarding allegations of Fraud, Waste and Abuse in the Medicaid program. Referrals can come from: • Medicaid provider complaints. • Self-Initiated referrals based on information obtained from data queries, sister agencies, provider and community outreach or other external sources. • Financial audits which determine funds were not used as intended or which identify overpayments and disallowed costs.…

    • 585 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    Bayh-Dole Act 1970

    • 796 Words
    • 4 Pages

    Under the Hatch-Waxman regime, a brand-name company seeking 26 FDA approval for a new drug must file a new drug application (NDA). In addition to detailed information about the properties of the drug, the application must include "the patent number and the expiration date of any patent which claims the drug . . . or which claims a method of using such drug and with respect to which a claim of patent infringement could reasonably be asserted," and this information must be amended as new patents are issued.27 After the drug is approved, the FDA must make this list public. 28 The FDA publication containing new drug information is known as the Orange Book, and it may be searched freely…

    • 796 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    Over Medicated Essay

    • 512 Words
    • 3 Pages

    Last year, pharmacist filled 4,468,929,929 prescriptions in the United States that is an 85 percent increase from just twenty years earlier (Carr, Rabkin, and Skinner 38). With these kinds of numbers, it must be obvious the process to develop drugs in America is working like a well-oiled machine, or is it? Prescription drug companies, the Food and Drug Administration (FDA) and independent research companies including universities all work together to develop improved medications. Each one has an unbiased, independent role to play in the process, however, over the years the unbiased independent part has become blurred. The Federal Government has made changes to regulations and health care policies, consequently, the prescription drug company’s…

    • 512 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    Cost Of Healthcare

    • 1442 Words
    • 6 Pages

    Physicians understand the high cost that comes with advanced medical technology, but most are ambivalent to it when it comes to individual patient care. A study of physician attitudes showed that most felt that the decision about whether a treatment is worth the cost should only be between the patient and doctor. Many also felt that medical intervention should always be offered, no matter the cost. 1. The United States is the only developed country in the world that does not have universal healthcare.…

    • 1442 Words
    • 6 Pages
    Great Essays
  • Great Essays

    A primary target market is described as a company’s main intended audience for the product they are selling. The product that Pfizer is selling is pharmacological medications that fit a certain segment of people with diseases that the company will be able to gain the most profit. In business, the producer and consumer should gain a profit from the sale of chemical to treat a disease and the consumer who finds relief from the disease. The primary target for Pfizer is both male & female, adults & children. The demographics of each of these segments incudes the financial status and social status of the customers.…

    • 1041 Words
    • 5 Pages
    Great Essays
  • Superior Essays

    Clinical trials have been performed at many sites around the world for many years to obtain approvals in multiple countries. The harmonization of regulatory processes developed by the ICH, drug patent laws, and country specific regulations is very important steps towards the product development, such as drug discovery, early development and preclinical testing, clinical trials and marketing authorizations. Nearly every country agrees to accept the ICH technical necessities for registration of pharmaceutical products for human use. Taking this into an account makes very easy to perform worldwide clinical trials by outsourcing and offshoring models to achieve the numerous regulatory and commercial incentives obtainable in many countries. The perfect time to build a regulatory strategy is before submitting an Investigational New Drug (IND) application.…

    • 1496 Words
    • 6 Pages
    Superior Essays
  • Improved Essays

    The core of the pharmaceutical industry problems consists of the expiration of patents, rising R&D expenses, and uncertainties facing new researched products and their abnormal methods of circulation of returns from said product. As rooted in the topic of this case AstraZeneca upholds the gold of innovatively changing the way medicine reaches patients. When patents are first granted there are procedures that followed before a drug reaches the marketplace. Due to the extended timeframe that is required for clinical trials, studies and organizational processes to tested and developed the revenue phase of the drug decreases (Hitt, Ireland, & Hoskisson, 2015). More specifically after the developed drug is ready for sale the patent remaining on these products are near expiration.…

    • 703 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    esentation analyses the events leading up to the 2004 merger between the pharmaceutical companies Sanofi-Synthelabo and Aventis. It reveals the social, commercial and political complexities and challenges of a merger process in which the defence of French national interests and regional capabilities competed with traditional ‘commercial’ narratives before the deal was closed. presentation critically evaluates the competing criteria adopted by government and industry to justify different merger scenarios and considers the implications for pharmaceutical innovation, industry consolidation and M&A theory The American economy greatest market for the pharmaceutical industry in 2004 the tax cuts and the lower interest rates stimulated expansion…

    • 1499 Words
    • 6 Pages
    Great Essays
  • Improved Essays

    i. The two companies that were selected are Pfizer and Johnson & Johnson. First of all, Pfizer, Inc. is a research-based, global biopharmaceutical company which it focuses in improving the health standards locally or globally by manufacturing vaccines and injectable biologic medicines. Basically Pfizer operates under a few business segments such as Global Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare and Global Established Pharmaceutical. Unlike Pfizer, Johnson & Johnson is an investment holding company which focuses its interest towards health care products.…

    • 826 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    In this report the role of the government in pharmaceutical regulation will be explored. Examples of how the government regulates the pharmaceutical industry will be presented; furthermore, each event will be analysed to determine whether the regulation was from a public or private interest theory perspective. In the end the goal is to reveal the dominant theory of regulation in the industry and which theory better predicts the outcome of events presented. The government’s role in the pharmaceutical industry always starts with a regulatory body.…

    • 984 Words
    • 4 Pages
    Improved Essays